Diagnosis and Treatment of Malassezia Dermatitis in Dogs and Cats - Clinical Consensus Guidelines

Sep 8, 2026

Upload by Miles

Clinical Consensus Guidelines from the World Association for Veterinary Dermatology synthesize evidence on Malassezia dermatitis in dogs and cats, covering organism biology, disease drivers, and practical decision-making for clinicians. The guidance addresses genus Malassezia characteristics, ecological and epidemiological patterns, and the mechanisms linking yeast growth to host immune responses. It outlines diagnostic approaches including cytology, culture, molecular identification, histopathology, and antifungal susceptibility testing, followed by therapy, prevention, and long-term management considerations, including zoonotic implications.

LanguageEnglish

CategoryPresentations

FormatDOCX

Pages138

Reading Time48 min

AccessFree to download

Diagnosis and treatment of Malassezia dermatitis in dogs and cats

The Genus Malassezia

Historical aspects

Ecology and epidemiology

Pathogenesis: virulence attributes amongst Malassezia spp.

Pathogenesis: immunological responses

Predisposing factors

Quantification by cytology and culture

Molecular approaches to identification

Histopathology

Antifungal susceptibility testing

Clinical signs in dogs

Clinical signs in cats

Diagnostic algorithm

Therapy

Prevention and long-term management

Zoonotic implications

Diagnosis and treatment of Malassezia dermatitis in dogs and cats. Clinical Consensus Guidelines of the World Association for Veterinary Dermatology Ross Bond*, Daniel O. Morris†, Jacques Guillot‡, Emmanuel Bensignor, David Robson¶, Kenneth V. Mason, Rui Kano, Peter B. Hill. *Department of Clinical Sciences and Services, Royal Veterinary College, Hawkshead Lane, North Mymms, Hatfield, Herts AL9 7TA, U.K. †Department of Clinical Studies-Philadelphia, School of Veterinary Medicine, University of Pennsylvania, 3900 Delancy Street, Philadelphia, PA 19104, USA. ‡École nationale vétérinaire d’Alfort, BioPôle Alfort, EA 7380 Dynamyc, UPEC, EnvA, Maisons Alfort, Ile-de-France, France Emmanuel Bensignor, Clinique Vétérinaire 17 Boulevard des Filles du Calvaire, 75003 Paris, France ¶Melbourne Veterinary Specialist Centre, 70 Blackburn Road Glen Waverley, 3150 Victoria, Australia Dermcare-vet PTY LTD, 7 Centenary Road, Slacks Creek, Queensland 4127, Australia Rui Kano, Department of Veterinary Pathobiology, Nihon University College of Bioresource Sciences, 1866 Kameino, Fujisawa, Kanagawa 252-0880, Japan Department of Veterinary Science, University of Adelaide, Adelaide, 5005 South Australia, Australia Corresponding author: rbond@rvc.ac.uk Conflicts of interest: In the past 5 years, RB has received funding from or otherwise collaborated with Dechra Veterinary Products, Bayer Animal Health, CEVA, MSD Animal Health and Elanco. DM has received honoraria, consulting fees and/or has collaborated with Pfizer Animal Health/Zoetis, Bayer, and Ceva Animal Health. JG has received funding from or otherwise collaborated with MSD Animal Health, CEVA, Bayer Animal Health and Boehringer-Ingelheim. DR has received funding from or otherwise collaborated with MSD Animal Health, Virbac Animal Health and Elanco. EB has consulted and lectured for Elanco and CEVA. KVM is Managing Director of Dermcare-vet PTY LTD. PBH has received honoraria and consulting fees from Pfizer/Zoetis and Elanco/Novartis. RK has no conflicts of interest to declare. Introduction The genus Malassezia Historical aspects Ecology and epidemiology Pathogenesis: virulence attributes amongst Malassezia spp. Pathogenesis: immunological responses Predisposing factors Quantification by cytology and culture Molecular approaches to identification Histopathology Antifungal susceptibility testing Clinical signs in dogs Clinical signs in cats Diagnostic algorithm Therapy Prevention and long-term management Zoonotic implications Synopsis of WAVD Clinical Consensus Guidelines on Malassezia dermatitis in dogs and cats. Introduction This section summarises the main conclusions from each of the section of the Consensus Guidelines. Literature reviews underpinning each of these summaries and recommendations are presented in the full text version below. 2. The Genus Malassezia Malassezia yeasts are unique in several ways, including their strict dependence on lipids, their cellular ultrastructure, and their dominance as eukaryotic residents on the skin of warm-blooded vertebrates. The taxonomy of the genus Malassezia is evolving. Eighteen species have been described so far but many other species are most probably present on the skin or mucosal sites of warm-blooded animals. Few phenotypic tests are available to differentiate Malassezia species and some of them may overlap. As a consequence, DNA sequencing (or other techniques such as mass spectrometry) may be required for specific identification. 3. Historical aspects The history of the association between Malassezia yeasts and their animal hosts has been long mired in controversy. Having been previously overlooked, canine Malassezia dermatitis has evolved from a controversial to a now routine diagnosis in small animal practice, with very significant welfare benefits for many patients. 4. Ecology and epidemiology Malassezia pachydermatis is a normal inhabitant of healthy canine skin and mucosae. M. pachydermatis also predominates on the skin of th

FAQs

Why is Malassezia identification sometimes difficult in veterinary practice?

Few phenotypic tests exist to differentiate Malassezia species, and some results may overlap. DNA sequencing and other methods such as mass spectrometry may be needed for specific identification.

What host and pathogen processes drive Malassezia dermatitis?

Yeast growth in the stratum corneum depends on yeast metabolic activity, including expression of cell wall and secreted virulence factors, and on the host’s innate and adaptive immune responses. Interactions with other skin commensals, especially staphylococci, may also contribute.

How should immunologic testing be used when diagnosing Malassezia dermatitis?

Serological and skin test reactivity can also occur in unaffected dogs, so immunologic tests must be interpreted alongside clinical and cytological findings. They should not be used as stand-alone diagnostic tests.

Sep 8, 2026

Upload by Miles